Bayer/MSD Verixiguat Approved in China to Treat Heart Failure
On May 19, the official website of China’s National Medical Products Administration (NMPA) announced that the innovative therapy vericiguat (Verquvo) jointly developed by Bayer and Merck & Co. (MSD) has been approved by priority review. Marketed for symptomatic chronic heart failure in stable adult patients with reduced ejection fraction (ejection fraction <45%) after recent heart failure decompensated intravenous therapy to reduce the risk of hospitalization for heart failure or the need for emergency IV diuretics risks of treatment.
Vericiguat is a soluble guanylate cyclase (sGC) stimulator that increases intracellular cGMP levels by directly stimulating sGC, thereby relaxing smooth muscle and dilating blood vessels. The launch of this drug provides a new treatment option for adult patients with symptomatic chronic heart failure.
Looking for chemical products? Let suppliers reach out to you!
You May Interested In
β-Nicotinamide Adenine Dinucleotide High Quality NAD+ CAS 53-84-9 Exclusive Production Factory CAS NO.53-84-9
$75/UNIT FOB
2026-07-06
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Bayer’s Flubendiamide Business Acquired by Tagros, Bringing a New Operator to Markets in Over 25 Countries Worldwide
-
Crystal Crop Protection Acquires Ethoxysulfuron Assets from Bayer AG
-
Bayer launches its new Fluopicolide fungicide in Brazil
-
Bayer Australia is officially certified and 60 products are produced locally
-
Bayer: Revenue of 13.765 billion euros( Q1)was in line with expectations
-
Bayer will introduce the first biocide for field crops that can effectively control coleopterans
-
Bayer degrades pesticide wastewater on farms to reduce pollution and carbon
-
Bayer forms the Alliance for Modern Agriculture to ensure continued access to Glyphosate for U.S. farmers
-
AgroGalaxy (Brazil) and Bayer terminate pesticide distribution cooperation
-
Bayer joins forces with Trinity Agtech to advance carbon reduction and data monitoring in agriculture
Recommend Reading
-
Lupin Secures Tentative U.S. Approval for Its Multiple Sclerosis Tablet
-
Novo Nordisk Submits Higher Dose of Wegovy One in Three Achieves Over 25 Percent Weight Loss
-
Over 70% of Patients Find Relief in Bayer’s New Breakthrough Drug for Breast Cancer Menopause Symptoms
-
Eisai Pharma Unveils Bold Plan: $100 Million Global Center Set to Transform Visakhapatnam Now
-
Vertex Pushes Gene Therapy Into Younger Children With Blood Disorders
-
Supply-Demand Contradiction Persists, Making Weak ABS Market Conditions Hard to Reverse
-
Polyvinyl Alcohol (PVA): Properties, Uses, and Industrial Applications
-
China Fuel Oil 180CST Market Trends Show Slight Decline in Mid-August
-
Suppliers Hold Firm on Prices, Slight Increase in Butadiene Market in China
-
Procter & Gamble Exits Pakistan Amid Economic Pressures, Ending Three Decades of Operations